Michael Rousseau - St Jude Insider

St Jude Medical Inc -- USA Stock  

USD 80.82  0.01  0.0124%

CEO and President COO and Director

Mr. Michael T. Rousseau was appointed as President Chief Executive Officer Director of the Company. effective January 1 2016. He was Chief Operating Officer of St. Jude Medical Inc. Mr. Rousseau joined St. Jude Medical in 1999 as Senior Vice President Cardiac Rhythm Management Global Marketing and later that year CRM marketing and sales were combined under his leadership. In January 2008 he was promoted to Group President and assumed responsibility for the company four product divisions. He was named Chief Operating Officer in 2014 overseeing global sales marketing technology development operations supply chain and quality functions
Age: 59  CEO Since 2016      
651 756-3301  www.sjm.com
Rousseau has helped to drive strategic transformation across virtually every area of the company. He was the architect of St. Jude Medical recent, significant integration of four product divisions into centralized global functions with a shared global vision, mission and growth strategy based on accelerating innovation. During this time and under Mr. Rousseau leadership, St. Jude Medical has achieved significant costsavings and operational efficiencies. He led the realignment of global supply chain management, restructured the company overseas manufacturing, and established a global quality system to put a global infrastructure in place to prepare the company for future growth. Recognizing the changing customer landscape, he broadened the company global customer service operations with a focus to enhance the experience for St. Jude Medical customers worldwide.

Michael Rousseau Latest Insider Activity

Michael Rousseau over three months ago via Macroaxis 
Abbott Laboratories exotic insider transaction detected

Management Efficiency

The company has Return on Asset of 0.08 % which means that on every $100 spent on asset it made $0.08 of profit. This is way below average.
The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29 which is OK given its current industry classification. St Jude Medical Inc has Current Ratio of 1.89 which is typical for the industry and considered as normal.

Similar Executives

Found 1 records

CEO Since

Matt MolchanDigirad Corporation
2013

Entity Summary

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical Inc (STJ) is traded on New York Stock Exchange in USA. It is located in MINNESOTA, U.S.A and employs 18,000 people. St Jude is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add St Jude Medical Inc to your portfolio

Top Management

St Jude Medical Leadership Team
David Lamb, Managing Director
Baroness Wheatcroft, Director
Ian Gascoigne, Managing Director
John Heinmiller, EVP
Tony Dunk, Director
Denis Gestin, President
Stephan Widensohler, Director
Donald Zurbay, CFO
Lisa Andrade, Executive
Wendy Yarno, Director
Iain Cornish, Director
Richard Devenuti, Director
Sarah Bates, Chairman
Jeffrey Dallager, President
Joel Becker, President
I Bae, President
Stuart Essig, Director
Andrew Croft, Director
Barbara Hill, Director
David Bellamy, Director
Roger Yates, Director
John Brown, Director
Daniel Starks, Chairman
Eric Fain, President
Elizabeth Kelly, Executive
Rachel Ellingson, President
Mark Carlson, President
Paul Bae, President
Michael Rousseau, CEO
Mark Murphy, VP
Scott Thome, President
Michael Rocca, Director
Simon Jeffreys, Director
Jeff Fecho, President
Jason Zellers, President
J Weigelt, Director
David Dvorak, Director
Stefan Widensohler, Director

Stock Performance

St Jude Performance Indicators